Volume 19, Number 12—December 2013
Research
Spontaneous Generation of Infectious Prion Disease in Transgenic Mice
Table 2
Infectivity of 113LBoPrP-Tg037 mice brain homogenates in BoPrP-Tg110*
Inoculum | Mean ± SEM survival time, days (no. diseased/no. tested)† |
||
---|---|---|---|
First passage | Second passage | Third passage | |
113LBoPrP-Tg037 (179 d old)‡ | 330 (1/5) | 272 ± 38 (6/6) | 252 ± 23 (6/6) |
113LBoPrP-Tg037-pool (150–250 d old)§ | 322, 406 (2/6) | 291 ± 23 (6/6) | 255 ± 14 (7/7) |
wtBoPrP-Tg110-pool (500–600 d old) | >650 (0/12) | >650 (0/12) | NA |
Normal mouse brain (500–600 d old) | >650 (0/12) | >650 (0/12) | NA |
Classical BSE-C (VLAPG817/00) ¶ | 295 ± 12 (6/6) | 265 ± 35 (6/6) | NA |
Atypical BSE-H (CASE 03–2095)# | 292 ± 5 (6/6) | 296 ± 7 (6/6) | NA |
Atypical BSE-L (02.2528)** | 207 ± 7 (6/6) | 199 ± 1 (6/6) | NA |
*BoPrP, bovine prion protein; 113L, leucine substitution at codon 113; wtBoPrP, wild-type bovine prion protein; NA, not available; BSE, bovine spongiform encephalopathy.
†Intracerebral inoculation with 2 mg brain tissue equivalent in BoPrP-Tg110+/+ (8× expression level).
‡Brain homogenate from a unique terminally sick animal.
§Brain homogenate from a pool of 5 terminally sick mice that died at 150–250 d of age.
¶Brainstem homogenate of 1 cow naturally infected with classical BSE (RQ 225:PG817/00) supplied by the Veterinary Laboratories Agency (New Haw,
#Data from Torres et al. (31).
**Brainstem samples from naturally affected cows given a diagnosis of atypical BSE-L by the Agence Française de Sécurité Sanitaire des Aliments (Lyon, France).
References
- McKinley MP, Bolton DC, Prusiner SB. A protease-resistant protein is a structural component of the scrapie prion. Cell. 1983;35:57–62 . DOIPubMedGoogle Scholar
- Prusiner SB. Novel proteinaceous infectious particles cause scrapie. Science. 1982;216:136–44. DOIPubMedGoogle Scholar
- Prusiner SB. Molecular biology of prion diseases. Science. 1991;252:1515–22. DOIPubMedGoogle Scholar
- Brown P, Gibbs CJ Jr, Rodgers-Johnson P, Asher DM, Sulima MP, Bacote A, Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol. 1994;35:513–29. DOIPubMedGoogle Scholar
- Tateishi J, Kitamoto T, Hoque MZ, Furukawa H. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology. 1996;46:532–7. DOIPubMedGoogle Scholar
- Mastrianni JA, Capellari S, Telling GC, Han D, Bosque P, Prusiner SB, Inherited prion disease caused by the V210I mutation: transmission to transgenic mice. Neurology. 2001;57:2198–205. DOIPubMedGoogle Scholar
- Nonno R, Bari MA, Cardone F, Vaccari G, Fazzi P, Dell’omo G, Efficient transmission and characterization of Creutzfeldt-Jakob disease strains in bank voles. PLoS Pathog. 2006;2:e12.. DOIPubMedGoogle Scholar
- Collinge J. Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry. 2005;76:906–19. DOIPubMedGoogle Scholar
- Collinge J, Clarke AR. A general model of prion strains and their pathogenicity. Science. 2007;318:930–6. DOIPubMedGoogle Scholar
- Chiesa R, Drisaldi B, Quaglio E, Migheli A, Piccardo P, Ghetti B, Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc Natl Acad Sci U S A. 2000;97:5574–9. DOIPubMedGoogle Scholar
- Castilla J, Gutierrez-Adan A, Brun A, Pintado B, Salguero FJ, Parra B, Transgenic mice expressing bovine PrP with a four extra repeat octapeptide insert mutation show a spontaneous, non-transmissible, neurodegenerative disease and an expedited course of BSE infection. FEBS Lett. 2005;579:6237–46. DOIPubMedGoogle Scholar
- Chiesa R, Piccardo P, Quaglio E, Drisaldi B, Si-Hoe SL, Takao M, Molecular distinction between pathogenic and infectious properties of the prion protein. J Virol. 2003;77:7611–22. DOIPubMedGoogle Scholar
- Hsiao KK, Scott M, Foster D, Groth DF, DeArmond SJ, Prusiner SB. Spontaneous neurodegeneration in transgenic mice with mutant prion protein. Science. 1990;250:1587–90. DOIPubMedGoogle Scholar
- Jackson WS, Borkowski AW, Faas H, Steele AD, King OD, Watson N, Spontaneous generation of prion infectivity in fatal familial insomnia knockin mice. Neuron. 2009;63:438–50. DOIPubMedGoogle Scholar
- Sigurdson CJ, Nilsson KP, Hornemann S, Heikenwalder M, Manco G, Schwarz P, De novo generation of a transmissible spongiform encephalopathy by mouse transgenesis. Proc Natl Acad Sci U S A. 2009;106:304–9. DOIPubMedGoogle Scholar
- Hsiao K, Baker HF, Crow TJ, Poulter M, Owen F, Terwilliger JD, Linkage of a prion protein missense variant to Gerstmann–Sträussler syndrome. Nature. 1989;338:342–5. DOIPubMedGoogle Scholar
- Ikeda SI, Yanagisawa N, Glenner GG, Allsop D. Gerstmann–Sträussler–Scheinker disease showing protein amyloid deposits in the peripheral regions of PrP immunoreactive amyloid plaques. Neurodegeneration. 1992;1:281–8.
- Castilla J, Gutierrez Adan A, Brun A, Pintado B, Ramirez MA, Parra B, Early detection of PrP(res) in BSE-infected bovine PrP transgenic mice. Arch Virol. 2003;148:677–91. DOIPubMedGoogle Scholar
- Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, A vector for expressing foreign genes in the brains and hearts of transgenic mice. Genet Anal. 1996;13:159–63. DOIPubMedGoogle Scholar
- Castilla J, Gutierrez-Adan A, Brun A, Pintado B, Parra B, Ramirez MA, Different behavior toward bovine spongiform encephalopathy infection of bovine prion protein transgenic mice with one extra repeat octapeptide insert mutation. J Neurosci. 2004;24:2156–64. DOIPubMedGoogle Scholar
- Sisó S, Puig B, Varea R, Vidal E, Acin C, Prinz M, Abnormal synaptic protein expression and cell death in murine scrapie. Acta Neuropathol. 2002;103:615–26. DOIPubMedGoogle Scholar
- Padilla D, Béringue V, Espinosa JC, Andreoletti O, Jaumain E, Reine F, Sheep and goat BSE propagate more efficiently than cattle BSE in human PrP transgenic mice. PLoS Pathog. 2011;7:e1001319. DOIPubMedGoogle Scholar
- Féraudet C, Morel N, Simon S, Volland H, Frobert Y, Creminon C, Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem. 2005;280:11247–58. DOIPubMedGoogle Scholar
- Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, Ironside JW, Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol. 2006;168:151–7. DOIPubMedGoogle Scholar
- Andréoletti O, Lacroux C, Chabert A, Monnereau L, Tabouret G, Lantier F, PrP(Sc) accumulation in placentas of ewes exposed to natural scrapie: influence of foetal PrP genotype and effect on ewe-to-lamb transmission. J Gen Virol. 2002;83:2607–16 .PubMedGoogle Scholar
- Fraser H, Dickinson AG. The sequential development of the brain lesion of scrapie in three strains of mice. J Comp Pathol. 1968;78:301–11. DOIPubMedGoogle Scholar
- Andréoletti O, Simon S, Lacroux C, Morel N, Tabouret G, Chabert A, PrP(Sc) accumulation in myocytes from sheep incubating natural scrapie. Nat Med. 2004;10:591–3. DOIPubMedGoogle Scholar
- Brun A, Castilla J, Ramirez MA, Prager K, Parra B, Salguero FJ, Proteinase K enhanced immunoreactivity of the prion protein-specific monoclonal antibody 2A11. Neurosci Res. 2004;48:75–83. DOIPubMedGoogle Scholar
- Espinosa JC, Andreoletti O, Castilla J, Herva ME, Morales M, Alamillo E, Sheep-passaged bovine spongiform encephalopathy agent exhibits altered pathobiological properties in bovine-PrP transgenic mice. J Virol. 2007;81:835–43. DOIPubMedGoogle Scholar
- Bruce ME, McConnell I, Fraser H, Dickinson AG. The disease characteristics of different strains of scrapie in Sinc congenic mouse lines: implications for the nature of the agent and host control of pathogenesis. J Gen Virol. 1991;72:595–603. DOIPubMedGoogle Scholar
- Priola SA, Chesebro B. Abnormal properties of prion protein with insertional mutations in different cell types. J Biol Chem. 1998;273:11980–5. DOIPubMedGoogle Scholar
- Hsiao KK, Groth D, Scott M, Yang SL, Serban H, Rapp D, Serial transmission in rodents of neurodegeneration from transgenic mice expressing mutant prion protein. Proc Natl Acad Sci U S A. 1994;91:9126–30. DOIPubMedGoogle Scholar
- Telling GC, Haga T, Torchia M, Tremblay P, DeArmond SJ, Prusiner SB. Interactions between wild-type and mutant prion proteins modulate neurodegeneration in transgenic mice. Genes Dev. 1996;10:1736–50. DOIPubMedGoogle Scholar
- Manson JC, Jamieson E, Baybutt H, Tuzi NL, Barron R, McConnell I, A single amino acid alteration (101L) introduced into murine PrP dramatically alters incubation time of transmissible spongiform encephalopathy. EMBO J. 1999;18:6855–64. DOIPubMedGoogle Scholar
- Asante EA, Gowland I, Grimshaw A, Linehan JM, Smidak M, Houghton R, Absence of spontaneous disease and comparative prion susceptibility of transgenic mice expressing mutant human prion proteins. J Gen Virol. 2009;90:546–58. DOIPubMedGoogle Scholar
- Nicholson EM, Brunelle BW, Richt JA, Kehrli ME Jr, Greenlee JJ. Identification of a heritable polymorphism in bovine PRNP associated with genetic transmissible spongiform encephalopathy: evidence of heritable BSE. PLoS ONE. 2008;3:e2912. DOIPubMedGoogle Scholar
- Stöhr J, Watts JC, Legname G, Oehler A, Lemus A, Nguyen HO, Spontaneous generation of anchorless prions in transgenic mice. Proc Natl Acad Sci U S A. 2011;108:21223–8 . DOIPubMedGoogle Scholar